MedPath

iSpecimen

🇺🇸United States
Ownership
-
Employees
53
Market Cap
-
Website
Introduction

iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.

Clinical Trials

3

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Collection and Distribution of Biospecimens for Novel Research

Conditions
Cancer
Autoimmune Diseases
Infectious Disease
Women's Health: High-Risk Pregnancy
Healthy
Gastrointestinal Complication
Dermatologic Disease
Blood Disease
First Posted Date
2021-10-18
Last Posted Date
2022-11-09
Lead Sponsor
iSpecimen Inc
Target Recruit Count
100000
Registration Number
NCT05080907
Locations
🇺🇸

Central Alabama, Montgomery, Alabama, United States

🇺🇸

Northern Alabama, Huntsville, Alabama, United States

🇺🇸

Southern Alabama Area, Mobile, Alabama, United States

and more 3 locations

Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

Withdrawn
Conditions
Pregnancy Related
Cancer
Gastro-Intestinal Disorder
Cardio-Respiratory Distress
Women's Health: Endometriosis
Autoimmune Diseases
Nephritis
Healthy
Neuro-Degenerative Disease
First Posted Date
2019-03-21
Last Posted Date
2022-11-14
Lead Sponsor
iSpecimen Inc
Registration Number
NCT03884400
Locations
🇺🇸

iSpecimen, Lexington, Massachusetts, United States

Collection and Distribution of Biospecimens for Novel Research Uses

Recruiting
Conditions
Dermatologic Disease
Gastrointestinal Complication
Healthy
Infectious Disease
Women's Health: High-Risk Pregnancy
Autoimmune Diseases
Blood Disease
Cancer
First Posted Date
2019-02-21
Last Posted Date
2022-11-09
Lead Sponsor
iSpecimen Inc
Target Recruit Count
10000
Registration Number
NCT03848962
Locations
🇺🇸

iSpecimen, Lexington, Massachusetts, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.